Delivery Order SPE2DB22D3501-SPE2DB24FVV90
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,804.78 firm fixed-price delivery order is for the supply of Lynparza 100 mg tablets. The award has no set-aside designation and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for AmerisourceBergen to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of Lynparza 100 mg tablets, a prescription pharmaceutical product. The award, valued at $59,036.64, was made by the Department of Defense's Medical Supply Chain agency on May 21, 2024, with a completion date of June 12, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,543.70 firm fixed-price delivery order is for the supply of LYNPARZA 100 MG TABLET UU 60S, a pharmaceutical product, with a performance period through July 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, with a ceiling value of $78,841.24, is a firm fixed price delivery order for the pharmaceutical product LYNPARZA 150 MG TABLET UU 120S. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp holds...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Lynparza 150 mg tablets. The contract, valued at $19,741.74, is a Firm Fixed Price Delivery Order type with a completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $9,870.87 firm fixed-price delivery order is for the supply of Lynparza 150 mg tablets, a prescription medication. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical products and medical supplies to DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lynparza 150 mg tablets, a specialty oncology medication. The fixed-price delivery order is valued at $9,572.69 and has a completion date of November 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.62 firm fixed-price delivery order covers the procurement of 4567090102 ! LYNPARZA 100 MG TABLET UU 120S, with a period of performance through February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lynparza 150 mg tablets. The contract has a ceiling value of $19,741.74 and a completion date of June 21, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, as a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,567.60, is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of May 2, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVV90Delivery Order
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is for the delivery of pharmaceutical products including Lynparza 150 mg tablets. The $9,774.74 firm fixed price contract was awarded by the Defense Logistics Agency, a defense agency, and has a completion date of June 25, 2024. The award is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 6/3/24 |